These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 20083525

  • 21. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.
    Patel MM, Tate JE, Selvarangan R, Daskalaki I, Jackson MA, Curns AT, Coffin S, Watson B, Hodinka R, Glass RI, Parashar UD.
    Pediatr Infect Dis J; 2007 Oct; 26(10):914-9. PubMed ID: 17901797
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
    Gastañaduy PA, Contreras-Roldán I, Bernart C, López B, Benoit SR, Xuya M, Muñoz F, Desai R, Quaye O, Tam KI, Evans-Bowen DK, Parashar UD, Patel M, McCracken JP.
    Clin Infect Dis; 2016 May 01; 62 Suppl 2():S121-6. PubMed ID: 27059345
    [Abstract] [Full Text] [Related]

  • 23. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
    Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H.
    Pediatr Infect Dis J; 2010 Apr 01; 29(4):319-23. PubMed ID: 19935446
    [Abstract] [Full Text] [Related]

  • 24. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community.
    Muhsen K, Chodick G, Goren S, Shalev V, Cohen D.
    Vaccine; 2010 Dec 10; 29(1):91-4. PubMed ID: 20969927
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
    Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, Racz ML.
    Pediatr Infect Dis J; 2010 Nov 10; 29(11):1019-22. PubMed ID: 20543761
    [Abstract] [Full Text] [Related]

  • 28. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M, Schödel F.
    Vaccine; 2009 Dec 30; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effectiveness of rotavirus vaccination in Spain.
    Martinón-Torres F, Bouzón Alejandro M, Redondo Collazo L, Sánchez Lastres JM, Pértega Díaz S, Seoane Pillado MT, Martinón Sánchez JM, ROTACOST research team.
    Hum Vaccin; 2011 Jul 30; 7(7):757-61. PubMed ID: 21521947
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States.
    Weycker D, Atwood MA, Standaert B, Krishnarajah G.
    Hum Vaccin Immunother; 2014 Jul 30; 10(7):2032-8. PubMed ID: 25424813
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children.
    Sahni LC, Boom JA, Patel MM, Baker CJ, Rench MA, Parashar UD, Tate JE.
    Vaccine; 2010 Aug 31; 28(38):6314-7. PubMed ID: 20637764
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.